Nanjing Cellnuo Biopharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files across a filed portfolio of 4 molecules.
| Molecule | Regulators | Docs |
|---|---|---|
| Insulin Aspart | US FDA | 1 |
| Retatrutide | US FDA | 1 |
| Semaglutide | US FDA | 1 |
| Tirzepatide | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Nanjing Cellnuo Biopharmaceutical comes back tiered against every other supplier able to file there.
Start for free